High Expression of PXMP4 in Hepatocellular Carcinoma Tissues

Overview

Journal Asian Pac J Cancer Prev

Specialty Oncology

Date 2024 Feb 28

PMID 38415547

Authors

Ming Ming Zhao

Zarina Awang

Farra Aidah Binti Jumuddin

Affiliations

Soon will be listed here.

Abstract

Objective: To analyze the high expression of peroxisome membrane protein 4 (PXMP4) in hepatocellular carcinoma (HCC) and its clinical significance.

Methods: The expression of PXMP4 mRNA in HCC tissues and corresponding adjacent tissues was detected by Q-PCR, and the expression of PXMP4 protein was detected by Western blot and immunohistochemistry. The correlation of PXMP4 protein expression with clinicopathological features and prognosis of HCC was analyzed.

Results: The expression levels of PXMP4 mRNA and protein in HCC tissues were significantly higher than those in adjacent tissues (P < 0.05), and its high expression was significantly correlated with tumor differentiation, lymph node metastasis, depth of invasion and TNM stage (P < 0.05). Patients with high expression of PXMP4 had a poor prognosis (P < 0.05).

Conclusion: The high expression of PXMP4 may promote the occurrence and development of HCC, and inhibition of PXMP4 may be one of the potential molecular targets for targeted therapy of HCC.

References

Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu M, Allen C . The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015. JAMA Oncol. 2017; 3(12):1683-1691. PMC: 5824275. DOI: 10.1001/jamaoncol.2017.3055. View

Llovet J, Montal R, Sia D, Finn R . Molecular therapies and precision medicine for hepatocellular carcinoma. Nat Rev Clin Oncol. 2018; 15(10):599-616. DOI: 10.1038/s41571-018-0073-4. View

Wang D, Li C, Xu Y, Xing Y, Qu L, Guo Y . Clinicopathological characteristics and prognosis of alpha-fetoprotein positive gastric cancer in Chinese patients. Int J Clin Exp Pathol. 2015; 8(6):6345-55. PMC: 4525844. View

Waterham H, Ferdinandusse S, Wanders R . Human disorders of peroxisome metabolism and biogenesis. Biochim Biophys Acta. 2015; 1863(5):922-33. DOI: 10.1016/j.bbamcr.2015.11.015. View

Park S, Jang J, Jeong S, Cho Y, Lee S, Kim S . Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma. Medicine (Baltimore). 2017; 96(11):e5811. PMC: 5369875. DOI: 10.1097/MD.0000000000005811. View

Rio D, Ares Jr M, Hannon G, Nilsen T . Purification of RNA using TRIzol (TRI reagent). Cold Spring Harb Protoc. 2010; 2010(6):pdb.prot5439. DOI: 10.1101/pdb.prot5439. View

Ye Y, Song Y, He S, Zhuang J, Wang G, Xia W . GINS2 promotes cell proliferation and inhibits cell apoptosis in thyroid cancer by regulating CITED2 and LOXL2. Cancer Gene Ther. 2018; 26(3-4):103-113. DOI: 10.1038/s41417-018-0045-y. View

Wei T, Zhang W, Tan Q, Cui X, Dai Z . Electrochemical Assay of the Alpha Fetoprotein-L3 Isoform Ratio To Improve the Diagnostic Accuracy of Hepatocellular Carcinoma. Anal Chem. 2018; 90(21):13051-13058. DOI: 10.1021/acs.analchem.8b04045. View

Shen Y, Li H, Hu Y, Zheng L, Wang Q . Loss of GINS2 inhibits cell proliferation and tumorigenesis in human gliomas. CNS Neurosci Ther. 2018; 25(2):273-287. PMC: 6488927. DOI: 10.1111/cns.13064. View

10.

Peng L, Song Z, Chen D, LingHu R, Wang Y, Zhang X . GINS2 regulates matrix metallopeptidase 9 expression and cancer stem cell property in human triple negative Breast cancer. Biomed Pharmacother. 2016; 84:1568-1574. DOI: 10.1016/j.biopha.2016.10.032. View

11.

Zheng M, Zhou Y, Yang X, Tang J, Wei D, Zhang Y . High GINS2 transcript level predicts poor prognosis and correlates with high histological grade and endocrine therapy resistance through mammary cancer stem cells in breast cancer patients. Breast Cancer Res Treat. 2014; 148(2):423-36. DOI: 10.1007/s10549-014-3172-7. View

12.

Yan T, Liang W, Jiang E, Ye A, Wu Q, Xi M . GINS2 regulates cell proliferation and apoptosis in human epithelial ovarian cancer. Oncol Lett. 2018; 16(2):2591-2598. PMC: 6036576. DOI: 10.3892/ol.2018.8944. View

13.

Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

14.

Farre J, Mahalingam S, Proietto M, Subramani S . Peroxisome biogenesis, membrane contact sites, and quality control. EMBO Rep. 2018; 20(1). PMC: 6322382. DOI: 10.15252/embr.201846864. View

15.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

16.

Blankestijn M, Bloks V, Struik D, Huijkman N, Kloosterhuis N, Wolters J . Mice with a deficiency in Peroxisomal Membrane Protein 4 (PXMP4) display mild changes in hepatic lipid metabolism. Sci Rep. 2022; 12(1):2512. PMC: 8847483. DOI: 10.1038/s41598-022-06479-y. View

17.

Ramos-Vara J . Technical aspects of immunohistochemistry. Vet Pathol. 2005; 42(4):405-26. DOI: 10.1354/vp.42-4-405. View

18.

Youssef A, Issa H, Omar M, Behiry E, Elfallah A, Hasaneen A . Serum human endothelial cell-specific molecule-1 (endocan) and vascular endothelial growth factor in cirrhotic HCV patients with hepatocellular carcinoma as predictors of mortality. Clin Exp Gastroenterol. 2018; 11:431-438. PMC: 6260127. DOI: 10.2147/CEG.S171339. View

19.

Hirano S . Western blot analysis. Methods Mol Biol. 2012; 926:87-97. DOI: 10.1007/978-1-62703-002-1_6. View

20.

Gallo-Oller G, Ordonez R, Dotor J . A new background subtraction method for Western blot densitometry band quantification through image analysis software. J Immunol Methods. 2018; 457:1-5. DOI: 10.1016/j.jim.2018.03.004. View